Overview
- 31 inspections across 29 sites are on record.
- 32 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-05-23.
At a glance
Inspections
31
Sites
29
Observations
32
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Otsuka ICU Medical LLC | 23 May 2014 | Human Drugs | View 483 → |
| MedImmune UK Limited | 29 Mar 2011 | On file | |
| Seqirus Vaccines Limited | 18 Mar 2011 | On file | |
| Roche Molecular Systems, Inc. | 27 Jan 2011 | On file | |
| BioReliance Corporation | 28 Oct 2010 | On file |
Sites inspected
Otsuka ICU Medical LLCAustin, United States1 insp.
MedImmune UK LimitedLiverpool, United Kingdom1 insp.
Seqirus Vaccines LimitedLiverpool, United Kingdom1 insp.
Roche Molecular Systems, Inc.Branchburg, United States1 insp.
BioReliance CorporationRockville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Cynthia Jim7 shared
Omotunde O Osunsanmi6 shared
Mihaly S Ligmond2 shared
Helen B Ricalde2 shared
Julie D Bringger2 shared
Sina Shojaee1 shared
Lloyd D Payne1 shared
Sharon K Thoma1 shared
Stephen D Eich1 shared
Full investigator report
Get the verbatim findings behind Rose M Ashley's 32 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site